Literature DB >> 22271127

Severe high-density lipoprotein deficiency associated with autoantibodies against lecithin:cholesterol acyltransferase in non-Hodgkin lymphoma.

Sara Simonelli1, Elisabetta Gianazza, Giuliana Mombelli, Alighiero Bondioli, Giovanni Ferraro, Silvana Penco, Cesare R Sirtori, Guido Franceschini, Laura Calabresi.   

Abstract

An antibody against the lecithin:cholesterol acyltransferase (LCAT) enzyme, which negates cholesterol esterification in plasma, causing severe high-density lipoprotein deficiency (HD), was identified in a woman with a large-cell non-Hodgkin lymphoma. Successful treatment of the lymphoma resulted in clearance of the antibody and complete correction of the defective cholesterol esterification and HD. To our knowledge, an acquired LCAT deficiency leading to severe HD has not been reported previously in association with a malignant disease, and this patient represents the first such documented case.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22271127     DOI: 10.1001/archinternmed.2011.661

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  A case of acquired lecithin:cholesterol acyltransferase deficiency with sarcoidosis that remitted spontaneously.

Authors:  Tanino Akiko; Takafumi Okura; Tomoaki Nagao; Masayoshi Kukida; Daijiro Enomoto; Ken-Ichi Miyoshi; Jitsuo Higaki; Masayuki Kuroda; Hideaki Bujo
Journal:  CEN Case Rep       Date:  2016-06-07

2.  Nephrotic syndrome caused by immune-mediated acquired LCAT deficiency.

Authors:  Satoshi Takahashi; Keiju Hiromura; Mayuko Tsukida; Yuko Ohishi; Hiroko Hamatani; Noriyuki Sakurai; Toru Sakairi; Hidekazu Ikeuchi; Yoriaki Kaneko; Akito Maeshima; Takashi Kuroiwa; Hideaki Yokoo; Takeo Aoki; Michio Nagata; Yoshihisa Nojima
Journal:  J Am Soc Nephrol       Date:  2013-04-25       Impact factor: 10.121

3.  Elevated interleukin-10: a new cause of dyslipidemia leading to severe HDL deficiency.

Authors:  Andreas G Moraitis; Lita A Freeman; Robert D Shamburek; Robert Wesley; Wyndham Wilson; Cliona M Grant; Susan Price; Stephen Demosky; Seth G Thacker; Abdalrahman Zarzour; Ronald L Hornung; Frank Pucino; Gyorgy Csako; Cheryl Yarboro; Iain B McInnes; Takashi Kuroiwa; Dimitrios Boumpas; V Koneti Rao; Gabor G Illei; Alan T Remaley
Journal:  J Clin Lipidol       Date:  2014-10-05       Impact factor: 4.766

Review 4.  Approach to the patient with extremely low HDL-cholesterol.

Authors:  Daniel J Rader; Emil M deGoma
Journal:  J Clin Endocrinol Metab       Date:  2012-10       Impact factor: 5.958

Review 5.  Revealing the Role of High-Density Lipoprotein in Colorectal Cancer.

Authors:  Aleksandra Zeljkovic; Jelena Vekic; Marija Mihajlovic; Tamara Gojkovic; Sandra Vladimirov; Dejan Zeljkovic; Vesna Spasojevic-Kalimanovska; Bratislav Trifunovic
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.